There's no foolproof way to know the future for Accelrys (NAS: ACCL) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock ...

Margins matter. The more Accelrys (NAS: ACCL) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

SAN DIEGO, Oct. 1, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced that it has appointed former Siemens ...

SAN DIEGO, Aug. 28, 2012 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced that the latest release of the ...

There's no foolproof way to know the future for Accelrys (Nasdaq: ACCL) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock ...

Earlier this month, medical and nanotech software specialist Accelrys (NASDAQ:ACCL) reported that its quarterly revenue had decreased 1%, from the previous quarter, to $20.2 million. Although the ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

Accelrys, Inc. announced that it has acquired QUMAS, a leading global provider of Cloud-based and on-premises enterprise compliance software supporting regulatory and quality operations in life ...

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/accelrys-announces-strategic-collaboration-with ...

SAN DIEGO--(BUSINESS WIRE)--Accelrys, Inc. (NASDAQ:ACCL), a leading scientific enterprise R&D software and services company, today announced a new release of the Discovery Studio® life sciences ...